An Open-label Extension Study To Evaluate Safety Of PF-06252616 In Boys With Duchenne Muscular Dystrophy
Clinical trial NCT02907619 · TERMINATED
Trial details
- NCT number
- NCT02907619
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-13
- Primary completion
- 2018-11-22
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.